Career history of Kevin Patrick Lynch
Former positions of Kevin Patrick Lynch
| Companies | Position | Start | End |
|---|---|---|---|
| ANTENGENE CORPORATION LIMITED | Director/Board Member | 18/06/2021 | 16/12/2022 |
| Chief Tech/Sci/R&D Officer | 25/03/2021 | 16/12/2022 | |
| CELGENE | Corporate Officer/Principal | 01/01/2011 | 01/01/2019 |
Novartis Pharmaceuticals Australia Pty Ltd.
 Novartis Pharmaceuticals Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals Australia Pty Ltd. is a company based in Sydney, Australia. | Corporate Officer/Principal | - | - |
Statistics
International
| China | 2 |
| United States | 2 |
| Australia | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ANTENGENE CORPORATION LIMITED | Health Technology |
| Private companies | 2 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Novartis Pharmaceuticals Australia Pty Ltd.
Novartis Pharmaceuticals Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals Australia Pty Ltd. is a company based in Sydney, Australia. | Health Technology |
- Stock Market
- Insiders
- Kevin Patrick Lynch
- Experience
